Pharmaron Beijing Co., Ltd. (HKG:3759)
Hong Kong
· Delayed Price · Currency is HKD 13.40
-0.06 (-0.45%)
May 16, 2025, 4:08 PM HKT
Pharmaron Beijing Market Cap
Pharmaron Beijing has a market cap or net worth of 40.74 billion as of May 16, 2025. Its market cap has increased by 27.37% in one year.
Market Cap
40.74B
Enterprise Value
44.94B
Revenue
13.62B
Ranking
n/a
PE Ratio
20.34
Stock Price
13.40
Market Cap Chart
Since January 28, 2019, Pharmaron Beijing's market cap has increased from 8.42B to 40.74B, an increase of 383.81%. That is a compound annual growth rate of 28.43%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 193.02B |
| Hansoh Pharmaceutical Group Company | 139.43B |
| JD Health International | 129.52B |
| WuXi Biologics | 95.65B |
| Alibaba Health Information Technology | 84.43B |
| Innovent Biologics | 84.13B |
| Akeso | 74.95B |
| Sino Biopharmaceutical | 72.47B |